Cash flow Umicore

Equities

UMI

BE0974320526

Specialty Chemicals

Market Closed - Euronext Bruxelles Other stock markets 20:55:00 16/02/2026 +04			After hours 00:25:58
18.69 ^EUR	-1.89%		18.50	-1.02%

02-13	Diary - Europe's STOXX 600 Corporate Earnings Week Ahead	RE
02-10	Goldman Sachs Downgrades Umicore to Neutral, Cuts PT	MT

aa419ea54863fdfbc.UBqVG5Tu65VNFj9h6s_fTfmJzzxXNsySK2uCfiIM3xg.PEXdcd22qKwYL0USqIm1dM7o_UguboDqSSb3RkU_vm09QPxq2p2IwAFFfg

Published financial data: UMICORE

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	20.71B	24.05B	25.44B	18.27B	14.85B
Other Revenues, Total	6.17M	11.26M	13.83M	14.49M	14.22M
Total Revenues	20.72B	24.07B	25.45B	18.28B	14.87B
Cost of Goods Sold, Total	19.62B	22.5B	23.78B	16.76B	13.64B
Gross Profit	1.1B	1.57B	1.67B	1.52B	1.23B
Depreciation & Amortization - (IS)	275M	290M	303M	305M	299M
Other Operating Expenses	405M	367M	524M	580M	639M
Other Operating Expenses, Total	680M	657M	827M	886M	938M
Operating Income	420M	913M	840M	634M	290M
Interest Expense, Total	-61.66M	-64.46M	-81.4M	-110M	-114M
Interest And Investment Income	4.51M	14.12M	12.75M	32.62M	39.76M
Net Interest Expenses	-57.15M	-50.34M	-68.65M	-77.6M	-74.67M
Income (Loss) On Equity Invest.	-5.33M	17.35M	13.47M	399K	-48.58M
Currency Exchange Gains (Loss)	-56.01M	-24.84M	-27.7M	-8.34M	-17.9M
Other Non Operating Income (Expenses)	-14.68M	-14.43M	-30.77M	-17.6M	-16.86M
EBT, Excl. Unusual Items	287M	840M	726M	531M	132M
Restructuring Charges	-27.76M	-5.15M	-1.78M	-694K	-137M
Impairment of Goodwill	-	-	-	-	-16M
Gain (Loss) On Sale Of Investments	-	-	-	-5.08M	-
Gain (Loss) On Sale Of Assets	1.65M	799K	1.52M	-674K	-101K
Asset Writedown	-87.54M	-48.5M	-24.93M	-45.79M	-1.4B
Insurance Settlements	21.58M	18.41M	8.87M	2.98M	629K
Legal Settlements	569K	144K	10K	46K	-1.83M
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	195M	806M	710M	482M	-1.42B
Income Tax Expense	59.13M	179M	138M	105M	107M
Earnings From Continuing Operations	136M	627M	572M	377M	-1.53B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	136M	627M	572M	377M	-1.53B
Minority Interest	-5.4M	-7.99M	-2.52M	7.97M	51.2M
Net Income - (IS)	131M	619M	570M	385M	-1.48B
Net Income to Common Incl Extra Items	131M	619M	570M	385M	-1.48B
Net Income to Common Excl. Extra Items	131M	619M	570M	385M	-1.48B
Per Share Items
Net EPS - Basic	0.54	2.57	2.37	1.6	-6.15
Basic EPS - Continuing Operations	0.54	2.57	2.37	1.6	-6.15
Basic Weighted Average Shares Outstanding	241M	241M	240M	240M	240M
Net EPS - Diluted	0.54	2.56	2.37	1.6	-6.15
Diluted EPS - Continuing Operations	0.54	2.56	2.37	1.6	-6.15
Diluted Weighted Average Shares Outstanding	242M	242M	241M	240M	241M
Normalized Basic EPS	0.72	2.15	1.88	1.41	0.56
Normalized Diluted EPS	0.72	2.14	1.88	1.41	0.56
Dividend Per Share	0.75	0.8	0.8	0.8	0.5
Payout Ratio	46.07	29.17	33.7	49.94	-13
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	646M	1.15B	1.09B	894M	534M
EBITA	434M	926M	850M	642M	299M
EBIT	420M	913M	840M	634M	290M
Total Revenues (As Reported)	20.79B	24.23B	25.62B	18.41B	14.99B
Effective Tax Rate - (Ratio)	30.31	22.21	19.38	21.77	-7.51
Total Current Taxes	116M	202M	245M	172M	107M
Total Deferred Taxes	-56.54M	-22.83M	-107M	-67.31M	59K
Normalized Net Income	174M	517M	451M	340M	134M
Interest on Long-Term Debt	6K	11M	11.3M	11.8M	1.9M
Non-Cash Pension Expense	4.22M	2.97M	1.86M	10.02M	10.31M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	221M	232M	315M	270M	251M
Stock-Based Comp., COGS (Total)	10.11M	14.26M	11.82M	14.12M	6.88M
Total Stock-Based Compensation	10.11M	14.26M	11.82M	14.12M	6.88M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.01B	1.19B	1.24B	1.52B	2.01B
Total Cash And Short Term Investments	1.01B	1.19B	1.24B	1.52B	2.01B
Accounts Receivable, Total	1.34B	1.38B	1.3B	969M	771M
Other Receivables	217M	292M	394M	306M	403M
Notes Receivable	80K	169K	1.27M	249K	40K
Total Receivables	1.56B	1.67B	1.69B	1.28B	1.17B
Inventory	2.72B	2.87B	3.39B	2.85B	2.25B
Other Current Assets, Total	156M	211M	224M	170M	176M
Total Current Assets	5.45B	5.94B	6.55B	5.81B	5.61B
Gross Property Plant And Equipment	4.61B	5.02B	5.38B	6.04B	6.41B
Accumulated Depreciation	-2.44B	-2.66B	-2.85B	-3B	-4.02B
Net Property Plant And Equipment	2.16B	2.35B	2.53B	3.04B	2.39B
Long-term Investments	148M	169M	181M	334M	611M
Goodwill	156M	159M	158M	158M	155M
Other Intangibles, Total	152M	145M	148M	189M	211M
Loans Receivable Long-Term	3.25M	2.61M	2.59M	2.44M	3.65M
Deferred Tax Assets Long-Term	222M	219M	316M	370M	378M
Deferred Charges Long-Term	38.52M	36.01M	36.91M	34.01M	21.28M
Other Long-Term Assets, Total	11.76M	20.67M	18.71M	29.69M	27.34M
Total Assets	8.34B	9.05B	9.94B	9.97B	9.41B
Liabilities
Accounts Payable, Total	1.9B	2.2B	2.25B	1.77B	1.65B
Accrued Expenses, Total	352M	459M	583M	496M	605M
Short-term Borrowings	697M	411M	460M	562M	529M
Current Portion of Long-Term Debt	21.95M	20M	241M	151M	570M
Current Portion of Leases	-	-	16.02M	16.16M	20.75M
Current Income Taxes Payable	161M	197M	262M	223M	208M
Unearned Revenue Current, Total	32.18M	29.85M	33.06M	27.92M	38.26M
Other Current Liabilities	199M	166M	288M	347M	730M
Total Current Liabilities	3.36B	3.48B	4.13B	3.6B	4.35B
Long-Term Debt	1.65B	1.66B	1.59B	1.97B	2.26B
Long-Term Leases	52.86M	62.89M	40.71M	50.7M	54.51M
Unearned Revenue Non Current	17.82M	40.82M	41.69M	56.41M	55.4M
Pension & Other Post Retirement Benefits	426M	387M	286M	315M	304M
Deferred Tax Liability Non Current	22.85M	24.29M	30.03M	28.74M	24.72M
Other Non Current Liabilities	188M	222M	258M	253M	437M
Total Liabilities	5.72B	5.88B	6.38B	6.27B	7.49B
Common Stock, Total	1.38B	1.38B	1.38B	1.38B	1.38B
Retained Earnings	1.75B	2.15B	2.53B	2.72B	1.07B
Treasury Stock	-209M	-226M	-266M	-262M	-260M
Comprehensive Income and Other	-368M	-196M	-128M	-177M	-259M
Total Common Equity	2.56B	3.11B	3.52B	3.66B	1.94B
Minority Interest	64.67M	54.39M	49.57M	36.36M	-16.18M
Total Equity	2.62B	3.17B	3.57B	3.7B	1.92B
Total Liabilities And Equity	8.34B	9.05B	9.94B	9.97B	9.41B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	241M	241M	240M	240M	240M
ECS Total Common Shares Outstanding	241M	241M	240M	240M	240M
Book Value / Share	10.63	12.93	14.64	15.23	8.06
Tangible Book Value	2.25B	2.81B	3.21B	3.31B	1.57B
Tangible Book Value Per Share	9.34	11.67	13.36	13.79	6.54
Total Debt	2.42B	2.15B	2.34B	2.75B	3.44B
Net Debt	1.41B	960M	1.1B	1.23B	1.42B
Debt Equivalent of Unfunded Proj. Benefit Obligation	426M	386M	282M	314M	303M
Minority Interest, Total (Incl. Fin. Div)	64.67M	54.39M	49.57M	36.36M	-16.18M
Equity Method Investments, Total	140M	155M	159M	315M	588M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	102M	111M	126M	133M	129M
Inventories - Work In Process, Total	7.5M	-10.63M	11.69M	6.06M	6.23M
Inventories - Finished Goods, Total	2.71B	2.87B	3.39B	2.84B	2.25B
Inventories - Others	7.22M	12.06M	4.1M	6.53M	6.28M
Land - (BS)	1.24B	1.38B	1.45B	1.5B	1.65B
Machinery, Total	2.74B	2.98B	3.17B	3.24B	3.68B
Full Time Employees	10.58K	11.05K	11.56K	11.75K	11.25K
Part Time Employees	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	22.32M	18.77M	17.89M	16.34M	18.85M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	131M	619M	570M	385M	-1.48B
Depreciation & Amortization - CF	233M	248M	259M	272M	257M
Amortization of Goodwill and Intangible Assets - (CF)	14.24M	13.58M	9.92M	7.13M	8.92M
Depreciation & Amortization, Total	247M	262M	269M	279M	265M
Amortization of Deferred Charges, Total - (CF)	20.98M	17.54M	17.34M	19.19M	19.71M
(Gain) Loss From Sale Of Asset	-760K	-1.76M	-7.73M	5.54M	97K
(Gain) Loss on Sale of Investments - (CF)	-	-	811K	444K	236K
Asset Writedown & Restructuring Costs	87.54M	48.5M	24.93M	45.79M	1.42B
(Income) Loss On Equity Investments - (CF)	5.33M	-17.35M	-13.47M	-399K	48.58M
Stock-Based Compensation (CF)	10.11M	14.26M	11.82M	14.12M	6.88M
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	131M	149M	104M	-52.92M	198M
Change In Accounts Receivable	-238M	-171M	-28.66M	458M	133M
Change In Inventories	-256M	-151M	-525M	544M	598M
Change In Accounts Payable	531M	450M	367M	-511M	378M
Change in Other Net Operating Assets	-142M	39.57M	-156M	-144M	-718M
Cash from Operations	528M	1.26B	634M	1.04B	869M
Capital Expenditure	-391M	-380M	-459M	-807M	-526M
Sale of Property, Plant, and Equipment	1.48M	1.99M	6.13M	9.67M	893K
Cash Acquisitions	-156K	-53.87M	-	-	-18.17M
Divestitures	518K	1.42M	6.21M	9.1M	-
Sale (Purchase) of Intangible assets	-37.44M	-36.23M	-32.37M	-77.27M	-56.03M
Investment in Marketable and Equity Securities, Total	-1.63M	-5.01M	-	-83.45M	-175M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-752K	-170K	-1.88M	727K	-1.31M
Other Investing Activities, Total	1K	-	-	-	-
Cash from Investing	-429M	-471M	-481M	-949M	-776M
Long-Term Debt Issued, Total	806M	-	215M	399M	2.06B
Total Debt Issued	806M	-	215M	399M	2.06B
Long-Term Debt Repaid, Total	-19.8M	-351M	-20.05M	-20.06M	-1.4B
Total Debt Repaid	-19.8M	-351M	-20.05M	-20.06M	-1.4B
Issuance of Common Stock	-	-	-	2.27M	-
Repurchase of Common Stock	-26.95M	-22.16M	-43.18M	-	-
Common Dividends Paid	-60.14M	-181M	-192M	-192M	-192M
Common & Preferred Stock Dividends Paid	-60.14M	-181M	-192M	-192M	-192M
Other Financing Activities, Total	-61.07M	-48.42M	-71.85M	-59.17M	-51.12M
Cash from Financing	638M	-602M	-113M	129M	413M
Foreign Exchange Rate Adjustments	25.46M	-20.08M	14.16M	19.22M	3.57M
Miscellaneous Cash Flow Adjustments	1K	-	-	-	-
Net Change in Cash	762M	165M	55.02M	242M	510M
Supplemental Items
Cash Interest Paid	59.69M	54.51M	70.16M	84.66M	86.47M
Cash Income Tax Paid (Refund)	78.96M	175M	216M	209M	114M
Levered Free Cash Flow	107M	504M	88.54M	219M	880M
Unlevered Free Cash Flow	146M	544M	139M	287M	951M
Change In Net Working Capital	-34.44M	-95.62M	192M	-463M	-1.06B
Net Debt Issued / Repaid	786M	-351M	195M	378M	657M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.41	6.56	5.53	3.98	1.87
Return on Total Capital	5.57	11	9.35	6.42	3.07
Return On Equity %	5.15	21.66	17	10.38	-54.49
Return on Common Equity	5.07	21.83	17.19	10.73	-52.86
Margin Analysis
Gross Profit Margin %	5.31	6.52	6.55	8.32	8.26
EBITDA Margin %	3.12	4.8	4.28	4.89	3.59
EBITA Margin %	2.09	3.85	3.34	3.51	2.01
EBIT Margin %	2.03	3.79	3.3	3.47	1.95
Income From Continuing Operations Margin %	0.66	2.61	2.25	2.06	-10.3
Net Income Margin %	0.63	2.57	2.24	2.11	-9.95
Net Avail. For Common Margin %	0.63	2.57	2.24	2.11	-9.95
Normalized Net Income Margin	0.84	2.15	1.77	1.86	0.9
Levered Free Cash Flow Margin	0.52	2.09	0.35	1.2	5.92
Unlevered Free Cash Flow Margin	0.7	2.26	0.55	1.57	6.4
Asset Turnover
Asset Turnover	2.7	2.77	2.68	1.84	1.53
Fixed Assets Turnover	9.73	10.66	10.42	6.56	5.48
Receivables Turnover (Average Receivables)	16.61	17.69	19.05	16.14	17.08
Inventory Turnover (Average Inventory)	7.57	8.05	7.59	5.37	5.35
Short Term Liquidity
Current Ratio	1.62	1.71	1.58	1.62	1.29
Quick Ratio	0.77	0.82	0.71	0.78	0.73
Operating Cash Flow to Current Liabilities	0.16	0.36	0.15	0.29	0.2
Days Sales Outstanding (Average Receivables)	22.03	20.64	19.16	22.62	21.43
Days Outstanding Inventory (Average Inventory)	48.33	45.33	48.06	67.99	68.45
Average Days Payable Outstanding	30.96	32.98	33.39	45.28	48.04
Cash Conversion Cycle (Average Days)	39.4	32.99	33.84	45.33	41.84
Long Term Solvency
Total Debt/Equity	92.47	68.04	65.72	74.33	178.83
Total Debt / Total Capital	48.04	40.49	39.66	42.64	64.14
LT Debt/Equity	65.04	54.43	45.6	54.62	120.57
Long-Term Debt / Total Capital	33.79	32.39	27.52	31.33	43.24
Total Liabilities / Total Assets	68.57	64.98	64.13	62.9	79.58
EBIT / Interest Expense	6.81	14.16	10.32	5.76	2.53
EBITDA / Interest Expense	10.81	18.22	13.62	8.29	4.85
(EBITDA - Capex) / Interest Expense	4.46	12.33	7.98	0.96	0.26
Total Debt / EBITDA	3.64	1.83	2.11	3.01	6.19
Net Debt / EBITDA	2.12	0.82	1	1.35	2.56
Total Debt / (EBITDA - Capex)	8.81	2.71	3.61	25.87	117.5
Net Debt / (EBITDA - Capex)	5.14	1.21	1.7	11.6	48.69
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	18.42	16.17	5.75	-28.17	-18.67
Gross Profit, 1 Yr. Growth %	1.91	42.88	6.32	-8.83	-19.24
EBITDA, 1 Yr. Growth %	-1.27	86.45	-5.32	-17.75	-40.23
EBITA, 1 Yr. Growth %	-6.4	127.68	-7.74	-24.36	-53.38
EBIT, 1 Yr. Growth %	-6.32	132.48	-7.45	-24.31	-54.26
Earnings From Cont. Operations, 1 Yr. Growth %	-54.57	361.24	-8.7	-34.12	-506.01
Net Income, 1 Yr. Growth %	-54.64	374.19	-7.93	-32.43	-484.31
Normalized Net Income, 1 Yr. Growth %	-24.21	230.04	-12.19	-24.5	-60.65
Diluted EPS Before Extra, 1 Yr. Growth %	-54.62	374.07	-7.42	-32.49	-484.64
Accounts Receivable, 1 Yr. Growth %	17.02	2.34	-5.85	-25.22	-20.42
Inventory, 1 Yr. Growth %	10.39	5.55	18.28	-16.02	-21
Net Property, Plant and Equip., 1 Yr. Growth %	3.29	8.66	7.71	19.92	-21.28
Total Assets, 1 Yr. Growth %	18.76	8.44	9.92	0.23	-5.56
Tangible Book Value, 1 Yr. Growth %	-1.21	24.91	14.27	3.24	-52.56
Common Equity, 1 Yr. Growth %	-1.4	21.73	12.97	4.11	-47.07
Cash From Operations, 1 Yr. Growth %	10.25	138.22	-49.61	64.41	-16.68
Capital Expenditures, 1 Yr. Growth %	-26.07	-3.04	20.89	75.97	-34.85
Levered Free Cash Flow, 1 Yr. Growth %	-169.74	457.27	-82.31	149.91	303.42
Unlevered Free Cash Flow, 1 Yr. Growth %	-216.32	321.94	-74.22	107.79	231.51
Dividend Per Share, 1 Yr. Growth %	100	6.67	0	0	-37.5
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	22.85	17.29	10.84	-12.84	-23.57
Gross Profit, 2 Yr. CAGR %	-1.93	20.61	23.2	-1.55	-14.19
EBITDA, 2 Yr. CAGR %	-3.47	32.79	32.57	-11.83	-29.91
EBITA, 2 Yr. CAGR %	-8.99	41.33	44.54	-16.55	-40.64
EBIT, 2 Yr. CAGR %	-9	42.72	46.28	-16.39	-41.19
Earnings From Cont. Operations, 2 Yr. CAGR %	-35.61	44.75	105.21	-22.44	63.55
Net Income, 2 Yr. CAGR %	-35.83	46.65	108.95	-21.12	61.15
Normalized Net Income, 2 Yr. CAGR %	-19.94	50.22	69.72	-18.67	-45.53
Diluted EPS Before Extra, 2 Yr. CAGR %	-35.8	46.67	109.5	-20.94	61.14
Accounts Receivable, 2 Yr. CAGR %	24.23	9.43	-1.84	-16.09	-22.86
Inventory, 2 Yr. CAGR %	8.52	7.94	11.74	-0.33	-18.54
Net Property, Plant and Equip., 2 Yr. CAGR %	16.22	5.94	8.18	13.65	-2.84
Total Assets, 2 Yr. CAGR %	17.38	13.48	9.18	4.96	-2.71
Tangible Book Value, 2 Yr. CAGR %	-1.53	11.09	19.48	8.62	-30.02
Common Equity, 2 Yr. CAGR %	-1.01	9.56	17.27	8.45	-25.76
Cash From Operations, 2 Yr. CAGR %	339.92	62.07	9.56	-8.98	17.04
Capital Expenditures, 2 Yr. CAGR %	-8.34	-15.33	8.26	45.85	7.08
Levered Free Cash Flow, 2 Yr. CAGR %	-53.39	80.87	-1.02	-33.93	217.23
Unlevered Free Cash Flow, 2 Yr. CAGR %	-44.27	108.24	3.99	-27.1	162.27
Dividend Per Share, 2 Yr. CAGR %	0	46.06	3.28	0	-20.94
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	20.11	20.58	13.31	-4.08	-14.83
Gross Profit, 3 Yr. CAGR %	5.68	11.14	15.61	11.44	-7.84
EBITDA, 3 Yr. CAGR %	9.28	18.51	18.46	13.01	-22.56
EBITA, 3 Yr. CAGR %	8.39	20.91	22.38	16.4	-31.29
EBIT, 3 Yr. CAGR %	8.77	21.65	23.3	17.35	-31.64
Earnings From Cont. Operations, 3 Yr. CAGR %	-15.98	24.12	24.14	40.51	34.66
Net Income, 3 Yr. CAGR %	-14.92	24.99	25.57	43.42	33.72
Normalized Net Income, 3 Yr. CAGR %	-2.02	24.04	25.35	29.46	-36.18
Diluted EPS Before Extra, 3 Yr. CAGR %	-17.74	25.02	25.82	43.63	33.96
Accounts Receivable, 3 Yr. CAGR %	7.98	16.46	4.08	-10.35	-17.56
Inventory, 3 Yr. CAGR %	18.62	7.52	11.29	1.59	-7.76
Net Property, Plant and Equip., 3 Yr. CAGR %	18.47	13.64	6.53	11.96	0.55
Total Assets, 3 Yr. CAGR %	17.7	14.33	12.28	6.11	1.33
Tangible Book Value, 3 Yr. CAGR %	14.02	6.59	12.14	13.8	-17.59
Common Equity, 3 Yr. CAGR %	12.35	6.06	10.68	12.71	-14.61
Cash From Operations, 3 Yr. CAGR %	51.04	258.57	9.79	25.43	-11.62
Capital Expenditures, 3 Yr. CAGR %	3.7	-6.61	-4.66	27.29	11.5
Levered Free Cash Flow, 3 Yr. CAGR %	-28.41	0.63	-16.84	34.21	20.69
Unlevered Free Cash Flow, 3 Yr. CAGR %	-19.33	5	3.58	30.63	20.72
Dividend Per Share, 3 Yr. CAGR %	2.33	2.17	28.73	2.17	-14.5
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	16.39	18.17	16.31	5.9	-3.2
Gross Profit, 5 Yr. CAGR %	8.22	15.4	12.34	5.86	2.61
EBITDA, 5 Yr. CAGR %	10.72	21.78	17.05	5.2	-4
EBITA, 5 Yr. CAGR %	11.9	26.52	20.05	4.13	-8.41
EBIT, 5 Yr. CAGR %	11.55	26.95	20.83	4.59	-8.34
Earnings From Cont. Operations, 5 Yr. CAGR %	-3.3	26.75	20.09	2.84	38.61
Net Income, 5 Yr. CAGR %	-5.06	36.48	21.87	3.97	38.75
Normalized Net Income, 5 Yr. CAGR %	5.22	26.17	19.57	4.64	-10.23
Diluted EPS Before Extra, 5 Yr. CAGR %	-5.18	25.42	19.56	4.08	38.91
Accounts Receivable, 5 Yr. CAGR %	14.16	14.56	3.94	2.15	-7.67
Inventory, 5 Yr. CAGR %	20.87	19.27	15.82	4.31	-1.77
Net Property, Plant and Equip., 5 Yr. CAGR %	16.17	17.04	14.24	13.65	2.68
Total Assets, 5 Yr. CAGR %	15.66	16.89	14.21	10.48	6.03
Tangible Book Value, 5 Yr. CAGR %	8.13	12.94	16.17	7.4	-7.14
Common Equity, 5 Yr. CAGR %	8.1	11.71	14.29	7.01	-5.66
Cash From Operations, 5 Yr. CAGR %	14.78	26.75	32.84	107.2	12.64
Capital Expenditures, 5 Yr. CAGR %	13.87	12.89	5.5	11.62	-0.13
Levered Free Cash Flow, 5 Yr. CAGR %	37.46	54.95	-21.27	-15.06	41.71
Unlevered Free Cash Flow, 5 Yr. CAGR %	54.5	54.1	-12.89	-9.37	49.96
Dividend Per Share, 5 Yr. CAGR %	4.56	4.24	2.71	1.3	5.92